MIHAE KIM: Open Payments
NPI 1750714408 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 14 payments from 9 companies in 2025. Trend: 2023 $166 · 2024 $124 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 4 | $183 |
| ABBVIE INC. | 2 | $61 |
| Biogen, Inc. | 2 | $55 |
| Alexion Pharmaceuticals, Inc. | 1 | $35 |
| Merz Pharmaceuticals, LLC | 1 | $33 |
| GE HEALTHCARE | 1 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $25 |
| ARGENX US, INC. | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
Products named: NUPLAZID, LEQEMBI, ULTOMIRIS, UBRELVY, INBRIJA, VYALEV, CREXONT, VYVGART HYTRULO.
Industry payments across CA — which companies pay providers there.
